| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 42,455 | 34,507 | 23,034 | | Cost of Revenue | 13,157 | 8,229 | 5,334 | | | Gross Profit | 29,298 | 26,278 | 17,700 | | | Operating Expenses | | Research Development | 8,846 | 4,941 | 4,116 | | Selling General and Administrative | 41,862 | 32,462 | 21,714 | | Non Recurring | 3,081 |
-
|
-
| | Others | 1,988 | 1,126 | 126 | | | | Total Operating Expenses | 55,777 |
-
|
-
| | | | Operating Income or Loss | (26,479) | (12,251) | (8,256) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 229 | 1,858 | 290 | | Earnings Before Interest And Taxes | (26,250) | (10,393) | (7,966) | | Interest Expense |
-
|
-
| 116 | | Income Before Tax | (26,250) | (10,393) | (8,082) | | Income Tax Expense | 208 | 205 |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (26,458) | (10,598) | (8,082) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (26,458) | (10,598) | (8,082) | | Preferred Stock And Other Adjustments |
-
|
-
| (471) | | | Net Income Applicable To Common Shares | ($26,458) | ($10,598) | ($8,553) |
|
1.48% Nasdaq 
0.02 (0.70%) 
Income Statement
